Proteome Sciences (LON:PRM) Shares Down 25% – Here’s What Happened

Proteome Sciences plc (LON:PRM)’s share price fell 25% during trading on Friday . The stock traded as low as GBX 2 and last traded at GBX 2.10. 186,545 shares changed hands during trading, a decline of 24% from the average session volume of 244,199 shares. The stock had previously closed at GBX 2.80.

Proteome Sciences Stock Performance

The company has a debt-to-equity ratio of -258.66, a quick ratio of 0.37 and a current ratio of 0.20. The company has a market capitalization of £7.07 million, a PE ratio of -2.12 and a beta of 0.07. The company has a 50 day moving average price of GBX 1.88 and a 200 day moving average price of GBX 2.68.

Proteome Sciences (LON:PRM) last posted its quarterly earnings results on Thursday, September 25th. The company reported GBX (0.73) earnings per share (EPS) for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.